Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Treasury Shares (2020 - 2025)

Tango Therapeutics has reported Treasury Shares over the past 4 years, most recently at $1.3 million for Q4 2025.

  • Quarterly results put Treasury Shares at $1.3 million for Q4 2025, up 4.47% from a year ago — trailing twelve months through Dec 2025 was $1.3 million (up 4.47% YoY), and the annual figure for FY2025 was $1.3 million, up 4.47%.
  • Treasury Shares for Q4 2025 was $1.3 million at Tango Therapeutics, down from $1.3 million in the prior quarter.
  • Over the last five years, Treasury Shares for TNGX hit a ceiling of $1.5 million in Q1 2025 and a floor of $633626.0 in Q1 2023.
  • Median Treasury Shares over the past 3 years was $1.2 million (2024), compared with a mean of $1.1 million.
  • Biggest five-year swings in Treasury Shares: soared 97.98% in 2024 and later increased 4.47% in 2025.
  • Tango Therapeutics' Treasury Shares stood at $757514.0 in 2023, then skyrocketed by 59.64% to $1.2 million in 2024, then grew by 4.47% to $1.3 million in 2025.
  • The last three reported values for Treasury Shares were $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.